Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
Abstract Background Transaminase and creatinine elevations have been well described in adults treated with remdesivir for COVID-19. It is hypothesized that a similar safety profile exists in children with COVID-19 treated with remdesivir, but available data are limited, especially in children < 1...
| Published in: | BMC Infectious Diseases |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-024-09833-9 |
